Cancer BiologybioRxivPreprint
Pulsed priming with the FAK inhibitor narmafotinib enhances both gemcitabine/Abraxane and FOLFIRINOX chemotherapy response in pancreatic cancer
Kendelle Joan Murphy, Cecilia R. Chambers, Daniel A. Reed…·Paul Timpson
This paper shows that pulsed narmafotinib priming improves chemotherapy response in pancreatic cancer by reducing fibrosis and enhancing treatment efficacy.
DOI 10.64898/2026.07.23.740234